iOncologi Secures Foundational U.S. Patent As Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival With Cancer Immunotherapy (Bio Space))
UF startup iOncologi, Inc. announced that USPTO has granted a U.S. patent for a novel method using RNA-based formulations to enhance tumor responsiveness to immune checkpoint inhibitor (ICI) therapy.
New Imaging Method Helps Immune Cells Zero In on Cancer (UF News)
UF researchers are testing nanoparticle imaging to track dendritic cell migration in cancer immunotherapy, with the goal of improving treatment effectiveness.
Study Finds Most Cancer Patients Exposed to Misinformation; UF Researchers Pilot ‘Information Prescription’ (UF Health)
Ninety-three percent of patients with a new cancer diagnosis were exposed to at least one type of misinformation about cancer treatments, a UF Health Cancer Center study has found. Most patients encountered the misinformation — defined as unproven or disproven cancer treatments and myths or misconceptions — even when they weren’t looking for it. The findings have major […]
Scientists Discover New Target in Potential Pancreatic Cancer Treatment (UF Health)
UF researchers helped find a promising new way to attack and kill pancreatic cancer cells by identifying an overlooked weak spot on a protein that supercharges the lethal cancer’s growth.
Tech Tuesday: University of Florida Lab Works to Increase the Body’s Natural Defenses in Fighting Cancer (WCJB TV20)
In today’s Tech Tuesday, UF Innovate introduces a lab led by UF molecular toxicologist Donna Zhang, which is working to amplify the body’s natural defenses in the fight against cancer.
Surprising Finding Could Pave Way for Universal Cancer Vaccine
A University of Florida study found that, like a one-two punch, pairing a test vaccine with commonly used anticancer drugs known as immune checkpoint inhibitors triggered a strong antitumor response.
Antibody-Cancer Drug Combo Shows Promise Against Aggressive Lymphoma
A study from UF researchers shows that cancer-targeting antibodies combined with a natural compound from soil microbes form a powerful treatment against an aggressive type of blood cancer.
Scholastic Performance Is a Key Concern for Young Cancer Patients, UF Study Finds
UF researchers have found that young cancer patients need support with scholastic performance, which can serve as an empowering and motivating force during the challenges of treatment.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
Rise Therapeutics Receives FDA IND Clearance To Initiate Clinical Testing of R-5780 in Cancer
UF startup Rise Therapeutics announced that the U.S. FDA has accepted its investigational new drug (IND) application to proceed with a cancer Phase 1 clinical trial for its program candidate, R-5780.